Myasthenia gravis and glycopyrrolate.
D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D005260:Female; D006024:Glycopyrrolate / Q000627:therapeutic use*; D006801:Humans; D009157:Myasthenia Gravis / Q000188:drug therapy*; D009388:Neostigmine / Q000627:therapeutic use*; D011729:Pyridostigmine Bromide / Q000627:therapeutic use*; D011759:Pyrrolidines / Q000627:therapeutic use*
D002800:Cholinesterase Inhibitors; D011759:Pyrrolidines; D009388:Neostigmine; D011729:Pyridostigmine Bromide; D006024:Glycopyrrolate